Edition:
India

Cidara Therapeutics Inc (CDTX.OQ)

CDTX.OQ on NASDAQ Stock Exchange Global Market

4.35USD
19 Jul 2018
Change (% chg)

-- (--)
Prev Close
$4.35
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
43,360
52-wk High
$8.80
52-wk Low
$3.72

Latest Key Developments (Source: Significant Developments)

Cidara Therapeutics Inc To Offer Up To 12.5 Mln Shares By Selling Stockholders - SEC Filing
Friday, 22 Jun 2018 

June 21 (Reuters) - Cidara Therapeutics Inc ::CIDARA THERAPEUTICS INC FILES PROSPECTUS RELATED TO OFFERING UP TO 12.5 MILLION SHARES OF CO'S COMMON STOCK BY SELLING STOCKHOLDERS - SEC FILING.  Full Article

Cidara Therapeutics Says Entered First Amendment To Loan And Security Agreement With Pacific Western Bank
Tuesday, 19 Jun 2018 

June 18 (Reuters) - Cidara Therapeutics Inc ::CIDARA THERAPEUTICS INC - ON JUNE 13, ENTERED FIRST AMENDMENT TO ITS LOAN AND SECURITY AGREEMENT WITH PACIFIC WESTERN BANK DATED AS OF OCTOBER 3, 2016.CIDARA - AMENDMENT RESETS COVENANT TO REQUIRE CO TO ACHIEVE POSITIVE DATA FROM PART B OF THE STRIVE TRIAL ON OR PRIOR TO JULY 31, 2019 - SEC FILING.  Full Article

Cidara Therapeutics Files For Stock Shelf Of Up To $10 Mln
Monday, 21 May 2018 

May 21 (Reuters) - Cidara Therapeutics Inc ::CIDARA THERAPEUTICS INC FILES FOR STOCK SHELF OF UP TO $10 MILLION – SEC FILING.  Full Article

Cidara Therapeutics Completes Enrollment in Phase 2 Strive Trial for Antifungal Rezafungin
Tuesday, 28 Nov 2017 

Nov 28 (Reuters) - Cidara Therapeutics Inc ::CIDARA THERAPEUTICS COMPLETES ENROLLMENT IN PHASE 2 STRIVE TRIAL EVALUATING NOVEL ANTIFUNGAL REZAFUNGIN (CD101 IV) IN INVASIVE FUNGAL INFECTIONS.  Full Article

Cidara reports qtrly ‍basic and diluted net loss per share $0.73​
Thursday, 9 Nov 2017 

Nov 8 (Reuters) - Cidara Therapeutics Inc ::Cidara provides corporate update and reports third quarter 2017 financial results.Cidara Therapeutics Inc - qtrly ‍basic and diluted net loss per share $0.73​.Cidara Therapeutics Inc - qtrly ‍total operating expenses $12.2 million versus $12.3 million.Q3 earnings per share view $-0.94 -- Thomson Reuters I/B/E/S.  Full Article

Cidara Therapeutics prices public offering of 2.48 mln common shares at $10.10 per share
Friday, 7 Oct 2016 

Cidara Therapeutics Inc : Cidara Therapeutics announces pricing of public offering of common stock .Says public offering of 2.48 million common shares priced at $10.10per share.  Full Article

Cidara Therapeutics enters loan and security deal for $10 mln
Tuesday, 4 Oct 2016 

Cidara Therapeutics Inc :Entered into a loan and security agreement for $10.0 million -sec filing.  Full Article

Cidara Therapeutics posts Q2 loss per share $0.85
Friday, 12 Aug 2016 

Cidara Therapeutics Inc : Qtrly loss per share $0.85 .Q2 earnings per share view $-0.76 -- Thomson Reuters I/B/E/S.  Full Article